Postoperative Active Recovery

Sponsor
Oregon Health and Science University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05950633
Collaborator
(none)
80
1
2
17
4.7

Study Details

Study Description

Brief Summary

This is a study evaluating a novel active recovery program in the immediate postoperative period following pelvic reconstructive surgery.

Condition or Disease Intervention/Treatment Phase
  • Other: Standard of Care
  • Other: Active Recovery
N/A

Detailed Description

This is a randomized controlled trial comparing usual care postoperative restrictions and a novel new active recovery program to look at differences in pelvic floor function, patient quality of life, and mental health in between groups.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluating a Novel Active Recovery Program in the Immediate Postoperative Period Following Pelvic Reconstructive Surgery: A Randomized Control Trial
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Dec 30, 2024
Anticipated Study Completion Date :
Dec 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard of Care

Participants will receive standard postoperative instructions only

Other: Standard of Care
Participants will receive standard of care postoperative instructions

Active Comparator: Active Recovery

Participants will receive active recovery instructions with specific walking goals, abdominal strengthening exercises, and pelvic floor exercises

Other: Active Recovery
Participants will receive instructions to increase their fitness to walking at least 30 minutes a day for 5 days a week following surgery and abdominal and pelvic floor exercises will focus on abdominal wall strengthening and abdominal pressure management, urinary urgency and retention, bowel and constipation management

Outcome Measures

Primary Outcome Measures

  1. Change in the Pelvic Floor Distress Inventory-20 (PFDI-20) [Baseline to 12 weeks post-surgery]

    The change in the Pelvic Floor Distress Inventory-20 (PFDI-20) between arms from baseline to 12 weeks post-surgery. Participants will be asked to rate how much symptoms bother them from 0 (not at all) to 4 (quite a bit)

  2. Change in the Short Form Health Survey (SF-36) [Baseline to 12 weeks]

    The change in the Short Form Health Survey (SF-36) between arms from baseline to 12 weeks post-surgery. Participants will be asked to rate their overall health. Scores can range from 0 to 100

  3. Change in the Patient Health Questionnaire (PHQ-9) [Baseline to 12 weeks post-surgery]

    The change in the Patient Health Questionnaire (PHQ-9) between arms from baseline to 12 weeks post-surgery. Participants will be asked to rate how frequently problems have bothered them from 0 (not at all) to 4 (nearly every day)

  4. Change in the Patient Global Impression of Improvement (PGI-I) [Baseline to 12 weeks post-surgery]

    The change in the Patient Global Impressions of Improvement (PGI-I) between arms from baseline to 12 weeks post-surgery. Participants will be asked to rate their symptoms from 1 (very much better) to 7 (very much worse)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 89 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Between the ages of 18 and 89

  2. Undergoing minimally invasive apical prolapse reconstructive procedure at OHSU. This includes laparoscopic and robotic-assisted sacrocolpopexy, laparoscopic and vaginal uterosacral ligament suspension, and vaginal sacrospinous ligament fixation. We will include patients undergoing concomitant procedures such as hysterectomy and incontinence procedures.

  3. Have access to reliable email for communication and questionnaires.

Exclusion Criteria:
  1. Unable to consent

  2. Unable to read and complete questionnaires in English

  3. Unable to sustain 30 minutes of moderate walking/activity at baseline (self-reported)

  4. Use a mobility assistance device such as a walker/cane at baseline

  5. Balance or stability problems

  6. Patients on chronic opioids

Contacts and Locations

Locations

Site City State Country Postal Code
1 OHSU Portland Oregon United States 97239

Sponsors and Collaborators

  • Oregon Health and Science University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sara Cichowski, Principal Investigator, Oregon Health and Science University
ClinicalTrials.gov Identifier:
NCT05950633
Other Study ID Numbers:
  • OHSU IRB 25625
First Posted:
Jul 18, 2023
Last Update Posted:
Jul 18, 2023
Last Verified:
Jul 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 18, 2023